子社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 鄰近社群 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] 社群統計 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1611277(30.06%) 最後更新時間: 2024-11-28 18:37 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目876-900 / 2409. (共97頁) << < 31 32 33 34 35 36 37 38 39 40 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2017-10	Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review	Cancer Research and Treatment. 2017 Oct;49(4):851-868.
2017-10	Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin	FASEB Journal. 2017 Oct;31(10):4265-4276.
2017-10	The c.1085A>G genetic variant of CSF1R gene regulates tumor immunity by altering the proliferation, polarization, and function of macrophages	Clinical Cancer Research. 2017 Oct;23(20):6021-6030.
2017-10	The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer	Experimental Cell Research. 2017 Oct;359(2):458-465.
2017-10	First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma	Scientific Reports. 2017 Oct;7:Article number 14333.
2017-09-25	Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase/ROS-mediated NFkappaB redox signaling cascade	Scientific Reports. 2017 Sep 25;7:Article number 12283.
2017-09-22	New insights into the role of inflammation in the pathogenesis of atherosclerosis	International Journal of Molecular Sciences. 2017 Sep 22;18(10):Article number 2034.
2017-09-19	Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma	Scientific Reports. 2017 Sep 19;7:Article number 11893.
2017-09-16	The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors	Oncotarget. 2017 Sep 16;8(58):98068-98083.
2017-09-05	Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells	Oncotarget. 2017 Sep 5;8(45):78948-78964.
2017-09	G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response	Radiotherapy and Oncology. 2017 Sep;124(3):395-402.
2017-09	Estrogen and cigarette sidestream smoke particulate matter exhibit ERalpha-dependent tumor-promoting effects in lung adenocarcinoma cells	American Journal of Physiology. Lung Cellular and Molecular Physiology. 2017 Sep;313(3):L477-L490.
2017-09	KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model	Oncogene. 2017 Sep;36(39):5532-5543.
2017-09	Screening of peptide specific to cholangiocarcinoma cancer cells using an integrated microfluidic system and phage display technology	Microfluidics and Nanofluidics. 2017 Sep;21(9):Article number 145.
2017-09	A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients	Scientific Reports. 2017 Sep;7:Article number 11253.
2017-09	ATTRACTION-04 (ONO-4538-37): A randomized, multicenter, phase 2/3 study of nivolumab (Nivo) plus chemotherapy in patients (Pts) with previously untreated advanced or recurrent gastric (G) or gastroesophageal junction (GEJ) cancer	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 777TiP.
2017-09	ATTRACTION-05 (ONO-4538-38/BMS CA209844): A randomized, multicenter, double-blind, placebo-controlled Phase 3 study of Nivolumab (Nivo) in combination with adjuvant chemotherapy in pStage III gastric and esophagogastric junction (G/EGJ) cancer	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 778TiP.
2017-09	Inhibition of the ubiquitin-conjugating enzyme E2B restores the BCNU sensitivity of cancer cells by regulating MGMT ubiquitination	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 55P.
2017-09	Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alon	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 741P.
2017-09	Mutant KIT translocates into the nucleus and induces NFKBIB expression that leads to KIT expression in imatinib-resistant gastrointestinal stromal tumors	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 1679P.
2017-09	Interim safety and clinical activity of nivolumab (Nivo) in combination with S-1/capecitabine plus oxaliplatin in patients (pts) with previously untreated unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: part 1 study of ATTRACTION-04 (ONO-4538-37)	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 671P.
2017-09	A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02)	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 617O.
2017-08-29	Investigating the association between alcohol and risk of head and neck cancer in Taiwan	Scientific Reports. 2017 Aug 29;7:Article number 9701.
2017-08-12	Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase	Redox Biology. 2017 Aug 12;13:655-664.
2017-08-07	Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer	Oncogenesis. 2017 Aug 7;6:Article number e369.

顯示項目876-900 / 2409. (共97頁) << < 31 32 33 34 35 36 37 38 39 40 > >> 每頁顯示[10|25|50]項目